Get Fidelity’s perspective and expertise on sector investing strategies.
Stocks have fought back since the market melted down from "Brexit". While stocks are still in the red post-Brexit, and uncertainty remains regarding the potential investing implications, one result of the Brexit vote seems clear: According to Fed funds futures, a rate hike in 2016 now appears unlikely.1 If this is the case, earnings may shift back into focus for most investors.
Biotech investors have had a rough go of it in recent months. The S&P 500 Biotech Index has fallen around 20% since its high point in July of 2015, as investors have grown worried about the potential for regulatory policy changes that could affect drug pricing and valuations among stocks in the industry.
Unemployment continues to fall. Inflation and wage growth have finally started picking up. The bull market is in year seven. To many investors, the message is clear: Signs of the late stage of the business cycle have been rising.
There are myriad reasons to like ETFs. Similar to mutual funds, they allow you to access many parts of the market—stocks, bonds, sectors, industries, currencies, and more. Many ETFs are relatively low cost, and can be tax efficient. You can use them to build a diversified portfolio or implement a more targeted strategy.
Past performance is no guarantee of future results.
Find out why sector exposure matters and how sectors can help boost performance.
A look inside sectors
Get the latest sector news and insights to better manage your portfolio.